blank control group:placebo

4 trials

Sponsors

Affiliated Hospital of Shandong University of Traditional Chinese Medicine, Shandong University of Traditional Chinese Medicine, Jilin University First Hospital

Conditions

Poor Ovarian Responsacute coronary syndromepolycystic ovarian syndrome

Early Phase 1

Screening of immune markers of phlegm-dampness type PCOS based on single cell transcriptome sequencing and study on the intervention of traditional Chinese medicine for reducing phlegm-dampness

RecruitingITMCTR2100004800

Shandong University of Traditional Chinese Medicinepolycystic ovarian syndrome

Start: 2021-06-01Updated: 2023-02-20

Screening of immune markers of phlegm-dampness type PCOS based on single cell transcriptome sequencing and study on the intervention of traditional Chinese medicine for reducing phlegm-dampness

RecruitingChiCTR2100045997

Shandong University of Traditional Chinese Medicinepolycystic ovarian syndrome

Start: 2021-06-01Updated: 2021-12-13

Phase 1

Tolerance test for vicagrel multiple dosing

Active, not recruitingChiCTR-IIR-16009260

Jilin University First Hospitalacute coronary syndrome

Start: 2016-10-10Updated: 2017-04-18

Unknown Phase

Based on microRNA, the targets and molecular mechanisms of Chinese traditional treatment to improve the quality of egg cells were investigated

RecruitingChiCTR1800019798

Affiliated Hospital of Shandong University of Traditional Chinese MedicinePoor Ovarian Respons

Start: 2018-12-01Updated: 2018-12-04

Related Papers

Evaluation of Tolerability, Pharmacokinetics and Pharmacodynamics of Vicagrel, a Novel P2Y12 Antagonist, in Healthy Chinese Volunteers

Frontiers in Pharmacology2018-06-2021 citations